Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,606
datasets available to search
ShareScore release 0.9.0
Dataset results
1,606 results for “Chronic obstructive pulmonary disease”
Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT00676052. IPD Sharing: YES. Countries: 14. Publications: 1.
Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT02573870. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT05169424. IPD Sharing: NO. Countries: 1. Publications: 1.
PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01350128. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT00363896. IPD Sharing: Not stated. Countries: 16. Publications: 1.
A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01817764. IPD Sharing: YES. Countries: 7. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01009463. IPD Sharing: YES. Countries: 15. Publications: 5.
Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)
ClinicalTrials.gov study NCT03954132. IPD Sharing: YES. Countries: 1. Publications: 2.
Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT02551224. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COP
ClinicalTrials.gov study NCT01822899. IPD Sharing: YES. Countries: 8. Publications: 1.
Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT01437540. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients
ClinicalTrials.gov study NCT01054170. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT00677807. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History
ClinicalTrials.gov study NCT02155660. IPD Sharing: Not stated. Countries: 26. Publications: 2.
Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01119950. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Comprehensive Care Programme for Patients With Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT01108835. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01397890. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China
ClinicalTrials.gov study NCT04853225. IPD Sharing: NO. Countries: 1. Publications: 1.
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT00932646. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT00457977. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.